Amrutanjan Health Care Closes Trading Window from Jan 1, 2026 for Q3 FY26 Results

Amrutanjan Health Care Limited has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulat...

Amrutanjan Health Care Limited has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015 and the Company's Code of Conduct. The trading window will be closed for Designated Persons from January 01, 2026, until 48 hours after the declaration of the Unaudited Financial Results for the quarter ending December 31, 2025. Designated Persons have been advised not to engage in any transactions involving the company's securities during this period. The company has requested the stock exchanges to take this intimation on record.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Amrutanjan Health Care Limited in the news today?

Amrutanjan Health Care Limited (AMRUTANJAN) is in the news due to the announcement is a routine regulatory disclosure regarding the closure of the trading window, which is a standard procedure and does not inherently carry a positive or negative connotation for the company's performance.

Trading Window Disclosure
Amrutanjan Health Care LimitedAMRUTANJANhttps://prysm.fi/v2/analyze/AMRUTANJAN

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Amrutanjan Health Care Closes Trading Window from Jan 1, 2026 for Q3 FY26 Results

December 19, 2025, 09:11 AM

AI Sentiment Analysis

Amrutanjan Health Care Limited has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015 and the Company's Code of Conduct.

The trading window will be closed for Designated Persons from January 01, 2026, until 48 hours after the declaration of the Unaudited Financial Results for the quarter ending December 31, 2025.

Designated Persons have been advised not to engage in any transactions involving the company's securities during this period. The company has requested the stock exchanges to take this intimation on record.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained - “Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

Top Queries to Ask About Amrutanjan Health Care Limited

More News on Amrutanjan Health Care Limited

Discover more trending news on Prysm

View All